Pancreatic Cancer

Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.

The incidence of pancreatic cancer increased at a faster rate over time among women aged younger than 55 years compared with their male counterparts, according to research published in Gastroenterology.

Referrals from low-volume to high-volume centers appeared associated with longer OS among patients with pancreatic ductal adenocarcinoma, according to study results published in JAMA Surgery.

In a video interview, Benjamin Schlechter, MD, of Dana-Farber Cancer Institute, spoke about two presentations on using radiation palliatively presented at ASCO Gastrointestinal Cancers Symposium.

In a video interview, Benjamin Schlechter, MD, talked about a “fascinating, compelling and important study” that looked at liposomal irinotecan injection regimen vs. nab-paclitaxel and gemcitabine in metastatic pancreatic cancer.

Researchers at Cold Spring Harbor Laboratory have developed software that correctly deduces continental ancestry from tumor DNA and RNA.

Only 30% of individuals with neuroendocrine tumors rank living longer as their single top priority in treating their cancer, according to a study conducted by researchers at City of Hope.

Cancer burden among older adults with type 2 diabetes has increased in the past 2 decades while all-cause mortality rates at all ages have decreased, according to a 20-year population-based study published in Diabetologia.

Pancreatic cancer is among the deadliest malignancies, and those who specialize in its treatment eagerly embrace any tools that may help extend patient survival.

Use of artificial intelligence in medical imaging has increased rapidly across health care specialties, and oncology is no exception.